Provectus Biopharmaceuticals, Inc.

OTC:PVCT

0.1491 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Operating Activities:
Net Income -3.102-3.555-5.54-6.678-6.923-8.153-13.518-24.427-24.502-10.243-27.698-12.568-15.422-18.552-12.322-10.27-10.006-8.871-11.764-4.345-3.632-7.122-0.13-0.012
Depreciation & Amortization 0.0090.0110.0130.2420.6850.6850.6870.6840.6840.680.6770.6770.6780.680.680.680.7712.5274.9251.921.5160.1800
Deferred Income Tax -0.4390-0.06300000-0.147-6.56314.671-1.76813.418-2.1400-2.341-1.863-0.01600000
Stock Based Compensation 0.0030.0030.0240.1350.0230.0800.020.6710.5340.1420.1834.6473.760.8711.9462.3411.8620.01600000
Change In Working Capital 0.4730.4464.4722.142-0.0472.1832.483-1.7565.129-0.5770.0020.249-1.0870.5230.416-0.3690.4210.0220.081-0.1060.3710.1380.0040
Accounts Receivables -00.004-0.0010.050.0050.5280.2170.5181.6000000000000000
Inventory 0-0.0040.001-0.05-0.00500000000000000-0.022-0.073000
Accounts Payables -0.4180.8070.331-0.17-2.1860.0421.7990.0331.4460.0920.1050.142-0.3170.198-0.047-0.1880.39-0.025-0.06400000
Other Working Capital 0.891-0.3614.142.3122.1392.1410.684-1.7893.682-0.668-0.1040.106-0.770.3240.462-0.1810.0310.0470.145-0.0850.443000
Other Non Cash Items 0.4840.0530.0810.0740.0710.08-0.6423.5620.7552.3212.3131.969-19.4351.9981.7590.8912.9672.0472.9740.2160.2266.4360.1260.012
Operating Cash Flow -2.572-3.041-1.013-4.086-6.19-5.205-10.348-21.937-17.41-13.847-9.892-11.259-17.201-13.731-8.596-7.12-5.846-4.275-3.784-2.315-1.519-0.36900
Investing Activities:
Investments In Property Plant And Equipment 000000-0.030-0.006-0.071-0.007-0.016-0.0060-0.0060-0.022-0.022-0.014-0-0.003000
Acquisitions Net 0000000000000000-19.4820000000
Purchases Of Investments 000000000000000-3.986-19.716-17.317000000
Sales Maturities Of Investments 000000000000000819.48211000000
Other Investing Activites 000000000000000019.4820000.18000
Investing Cash Flow 000000-0.030-0.006-0.071-0.007-0.016-0.0060-0.0064.014-0.256-6.339-0.014-00.177000
Financing Activities:
Debt Repayment -2.192-0.26-0.248-0.106-6.413-4.476-9.30600000000000000000
Common Stock Issued 000.9620.4190.2690.080.0023.63513.65411.12318.4194.7919.766.7666.51905.8164.3738.6822.1750.2920.02500
Common Stock Repurchased 000000000000000000000-0.04800
Dividends Paid 0000000-2,045.7900-0.0290000000000000
Other Financing Activities -01.6283.313.28812.8985.079.3172,051.0790.554.4915.9834.7917.06711.8142.5242.645.4894.3471.984-0.0130.4961.10900
Financing Cash Flow 2.1921.3684.0243.66.7545.159.3188.92414.20415.61324.3744.79116.82718.589.0432.645.8164.37310.6662.1620.7891.08600
Other Information:
Effect Of Forex Changes On Cash -0.024-0.002-0.001-0.008-0.0240000000000000000000
Net Change In Cash -0.405-1.6753.01-0.4930.54-0.055-1.06-13.013-3.2131.69514.475-6.484-0.384.8490.441-0.467-0.286-6.2416.868-0.153-0.5540.71800
Cash At End Of Period 1.0271.4323.1070.0970.5910.0510.1061.16614.17917.39215.6961.2227.7068.0863.2372.7960.3520.6386.8790.0110.1640.71800